CytomX Therapeutics: Ended 3Q With $117.6M of Cash, Cash Equivalents and Investments >CTMX
CytomX Therapeutics: Ended 3Q With $117.6M of Cash, Cash Equivalents and Investments >CTMX
CytomX Therapeutics:第三季度以11760万美元的现金、现金等价物和投资结束 >CTMX
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册